Fennec Pharmaceuticals Inc (FENC) Insider Trading
- $7,299,977.50
- $12,716,777.64
- April 22, 2024
- Chris A Rallis
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 22, 2024 | COO | 22,223 | $9.32 | Sell | $207,118.36 | |
April 19, 2024 | COO | 22,222 | $9.34 | Sell | $207,553.48 | |
April 17, 2024 | COO | 22,222 | $9.91 | Sell | $220,220.02 | |
April 15, 2024 | COO | 22,222 | $10.30 | Sell | $228,886.60 | |
April 15, 2024 | Director | 800 | $10.45 | Sell | $8,360.00 | |
April 5, 2024 | CEO | 44,300 | $10.75 | Sell | $476,225.00 | |
April 3, 2024 | CEO | 40,584 | $10.78 | Sell | $437,495.52 | |
March 26, 2024 | Director | 2,114 | $10.97 | Sell | $23,190.58 | |
March 25, 2024 | CFO | 13,975 | $11.00 | Sell | $153,725.00 | |
Jan. 4, 2024 | CFO | 15,000 | $10.64 | Sell | $159,600.00 | |
Dec. 28, 2023 | CEO | 3,656 | $11.55 | Sell | $42,226.80 | |
Dec. 26, 2023 | Director | 1,390 | $10.90 | Sell | $15,151.00 | |
Nov. 20, 2023 | Director | 269 | $8.25 | Sell | $2,219.25 | |
Nov. 8, 2023 | CEO | 25,044 | $7.76 | Sell | $194,341.44 | |
Aug. 18, 2023 | Director | 673 | $7.85 | Sell | $5,283.05 | |
July 24, 2023 | Director | 6,796 | $8.17 | Sell | $55,523.32 | |
July 6, 2023 | Director | 2,207 | $8.47 | Sell | $18,693.29 | |
June 30, 2023 | CFO | 7,500 | $8.82 | Sell | $66,150.00 | |
June 28, 2023 | CFO | 10,000 | $8.99 | Sell | $89,900.00 | |
May 19, 2023 | Director | 1,758 | $7.36 | Sell | $12,938.88 | |
Dec. 30, 2022 | CFO | 5,500 | $9.61 | Sell | $52,855.00 | |
Dec. 30, 2022 | CEO | 10,000 | $9.62 | Sell | $96,200.00 | |
Dec. 28, 2022 | CFO | 11,000 | $9.61 | Sell | $105,710.00 | |
Dec. 28, 2022 | CEO | 13,740 | $9.59 | Sell | $131,766.60 | |
April 30, 2020 | Major Shareholder | 768,000 | $6.25 | Buy | $4,800,000.00 | |
March 28, 2018 | Major Shareholder | 914,745 | $10.61 | Sell | $9,705,444.45 | |
Dec. 12, 2017 | Major Shareholder | 294,115 | $8.50 | Buy | $2,499,977.50 |
Insiders are both buying and selling Fennec Pharmaceuticals Inc stock.
The insider traders at Fennec Pharmaceuticals Inc are: Chris A Rallis, Robert Andrade, Rosty Raykov, Adrian Haigh, Spa Essetifin, and Manchester Management Pr, Llc
The most active insider trader at Fennec Pharmaceuticals Inc is Chris A Rallis with 8 trades.
Manchester Management Pr, Llc has sold the most Fennec Pharmaceuticals Inc stock with a total value of $19,410,888.90.
Spa Essetifin has bought the most Fennec Pharmaceuticals Inc stock with a total value of $12,099,977.50.
The most recent insider trade for Fennec Pharmaceuticals Inc was on April 22, 2024.
The single biggest insider buy for Fennec Pharmaceuticals Inc was from Spa Essetifin with a total value of $4,800,000.00 on April 30, 2020.
The single biggest insider sell for Fennec Pharmaceuticals Inc was from Manchester Management Pr, Llc with a total value of $9,705,444.45 on March 28, 2018.